Picture EBD Group Startup Spotlight at BIO-Europe 2023 650x100px

Document › Details

Barry, Sion [Wales Online]. (2/2/17). "News: Arix Bioscience to Confirm Plans to Float in Move that Could Raise up to £100m. Arthurian Life Sciences Has Been Acquired by Arix and Is Now Considering a New Funding Round for the Wales Life Sciences Investme

	Organisation	Arix Bioscience plc (LSE: ARIX)
	Today	Arix Bioscience (Group)
	Group	Arix Bioscience (Group)
	Organisation 2	Arthurian Life Sciences Ltd.
	Group	Arix Bioscience (Group)
	Product	venture capital
	Product 2	LIFE SCIENCES
	Index term	Arix Bioscience–SEVERAL: investment, 201702 IPO £112m on Main Market of LSE
	Index term 2	Arthurian Life Sciences–Arix Bioscience: investment, 201702c acquisition of Arthurian by Arix
	Person	Evans, Christopher (Chris) (Arthurian Life Sciences + Merlin Biosciences + Chiroscience + Celsis + Enzymatix)
	Person 2	Peacock, Jonathan M. (Jon) (Arix Bioscience 201805 Chairman before Amgen + Novartis Pharmaceuticals AG CFO + McKinsey)

Original document
accessed by [iito] on 2017-02-02

Record changed: 2023-06-05

Picture EBD Group BIO-Europe 2023 Munich BEU23 650x200px

More documents for Arix Bioscience (Group)

[1] Evommune, Inc.. (4/26/23). "Press Release: Evommune Closes $50 Million Series B Financing to Advance Broad Pipeline of Therapies to Treat Chronic Inflammatory Diseases". Palo Alto, CA....
[2] UCB S.A.. (3/9/23). "Press Release: UCB’s Board of Directors Appoints Jonathan Peacock as New Chair". Brussels....
[3] Sorriso Pharmaceuticals, Inc.. (12/22/21). "Press Release: Sorriso Pharmaceuticals Launches with $31 Million to Develop Novel Class of Orally Delivered Cytokine Antibodies to Treat Inflammatory Conditions". Salt Lake City, UT....
[4] Arix Bioscience plc. (12/22/21). "Press Release: Arix Bioscience Co-leads $31 Million Series A Financing for New Portfolio Company Sorriso Pharmaceuticals". London....
[5] Rentschler Biopharma SE. (9/20/21). "Press Release: Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer, Strengthening Scientific Focus". Laupheim & Milford, MA....
[6] Pyxis Oncology, Inc.. (3/30/21). "Press Release: Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics". Cambridge, MA....
[7] Arix Bioscience plc. (3/24/21). "Press Release: Strategy Implementation Review". London....
[8] Arix Bioscience plc. (11/5/20). "Press Release: VelosBio to Be Acquired by Merck for $2.75 Billion". London....
[9] GenSight Biologics S.A.. (10/22/20). "Press Release: GenSight Biologics Successfully Raises €25 Million in an Oversubscribed Private Placement With US and European Institutional Investors". Paris....
[10] VelosBio Inc.. (7/8/20). "Press Release: VelosBio Raises $137 Million in Series B Financing to Advance Development of ROR1-Directed Therapeutics in Oncology"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]